Tatyana Daniels

Prior to joining Technology Partners in 2007, Ms. Daniels spent several years with Pfizer in positions of increasing responsibility focused on strategy, business development and clinical trial acceleration, where she managed an innovative clinical trial program that achieves significantly faster clinical trial timelines.
In addition, Ms. Daniels led a physician segmentation strategy for Johnson & Johnson’s interventional cardiology division.
Previously, Ms. Daniels provided investment research coverage for emerging and established medical device companies, including MiniMed, VISX, Summit Autonomous, American Medical Systems and Guidant at Hambrecht & Quist (and its successor firms Chase H&Q and JPMorgan) as well as spearheaded coverage of the ophthalmology sector.
Ms. Daniels began her Wall Street career at Salomon Smith Barney, where she originated and executed transactions raising $12 billion on behalf of clients.
She also served as a Capital Markets Advisor for the U.S.
Department of Health & Human Services’ Centers for Medicare and Medicaid Services.
Ms. Daniels earned an MBA from Harvard Business School, where she and her team won the prestigious Business Plan Contest and a B.S.
with honors from Carnegie Melon University.
She has studied art at the International School of Painting, Drawing, and Sculpture in Italy.